TABLE 3

Biodistribution Results and Tumor–to–Normal Tissue Ratios of 64Cu- and 68Ga-DOTA-c(RGDfK) in Nude Mice Bearing U87MG Tumors

64Cu68Ga
Organ1 h1-h blocking*18 h1 h1-h blocking*
Blood0.63 ± 0.140.56 ± 0.230.42 ± 0.150.38 ± 0.070.60 ± 0.14
Heart1.01 ± 0.210.70 ± 0.010.93 ± 0.160.35 ± 0.080.20 ± 0.05
Liver5.46 ± 1.313.14 ± 0.442.59 ± 0.811.60 ± 0.270.48 ± 0.10
Spleen1.71 ± 0.270.73 ± 0.011.30 ± 0.271.34 ± 0.210.36 ± 0.09
Lung1.58 ± 0.302.38 ± 1.071.51 ± 0.440.87 ± 0.120.58 ± 0.11
Kidney3.31 ± 0.122.96 ± 0.312.03 ± 0.652.24 ± 0.341.95 ± 0.68
Stomach2.65 ± 0.501.31 ± 0.321.35 ± 0.621.50 ± 0.360.57 ± 0.11
Intestine2.79 ± 0.521.40 ± 0.321.92 ± 0.581.79 ± 0.300.53 ± 0.08
Adrenal4.02 ± 1.401.03 ± 0.242.31 ± 0.724.87 ± 1.210.71 ± 0.04
Pancreas0.68 ± 0.080.34 ± 0.130.53 ± 0.150.29 ± 0.050.18 ± 0.01
Muscle0.42 ± 0.080.23 ± 0.080.23 ± 0.010.29 ± 0.040.18 ± 0.02
Bone0.53 ± 0.090.51 ± 0.080.39 ± 0.140.35 ± 0.050.11 ± 0.05
Tumor3.97 ± 0.481.57 ± 0.133.23 ± 0.753.47 ± 0.780.89 ± 0.05
Tumor-to-nontumor ratios
 Tumor-to-blood6.46 ± 1.578.30 ± 2.589.24 ± 1.12
 Tumor-to-liver0.77 ± 0.241.35 ± 0.502.25 ± 0.37
 Tumor-to-kidney1.20 ± 0.151.73 ± 0.651.57 ± 0.14
 Tumor-to-intestine1.46 ± 0.291.82 ± 0.661.95 ± 0.16
 Tumor-to-muscles9.94 ± 3.4414.30 ± 0.4012.37 ± 1.81
  • * Coinjection of c(RGDfV) (5 mg/kg).

  • Data are %IA/g ± SD (n = 4–7).